Navigation Links
BioLineRx Announces New Positive Results in Phase 2a trial for Orally Available Inflammatory Bowel Disease Treatment
Date:11/26/2013

-9). It also acts as a specific suppressor of acetylcholinesterase, a key enzyme involved in neurological pathways. This dual effect enables a unique combination of both neurological and anti-inflammatory properties. In addition, BL-7040 has an indirect effect on the production of pro-inflammatory cytokines as well as anti-inflammatory properties via modulation of macrophages. BL-7040 was invented by Prof. Hermona Soreq from the Hebrew University of Jerusalem, and is being developed by BioLineRx under a worldwide exclusive license from Yissum Research and Development Company, the technology transfer company of the Hebrew University.

About Inflammatory Bowel Disease (IBD)              
Inflammatory bowel disease is a chronic inflammatory gastrointestinal disease characterized by chronic abdominal pain, discomfort, bloating and alteration of bowel habits. Over two million people are afflicted with IBD in the seven major markets. Sales of existing drugs in the seven major markets were estimated at over $7.5 billion in 2012, of which $5.6 billion were US-based sales. By 2020, sales in the seven major markets are expected to be over $8 billion, of which $6.5 billion are expected to be in the US. Despite these numbers, there is still a significant portion of IBD patients who are underserved by current pharmacological treatments.

About BioLineRx        
BioLineRx is a publicly-traded biopharmaceutical development company dedicated to building a portfolio of products for unmet medical needs, as well as those with advantages over currently available therapies. The Company in-licenses novel compounds primarily from academic institutions and biotech companies based in Israel, develops them through pre-clinical and/or clinical stages,
'/>"/>

SOURCE BioLineRx
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. BioLineRx Reports Publication in Peer Review Journal of Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma
2. BioLineRx Reports Third Quarter 2013 Financial Results
3. BioLineRx to Report Third Quarter 2013 Results on November 13, 2013
4. BioLineRx to Hold Analyst and Investor Day in New York on November 21, 2013
5. BioLineRx Receives Regulatory Approval to Commence Phase 1/2 Trial for Novel Treatment of Celiac Disease
6. BioLineRx Announces In-Licensing of BL-9020, for Treatment of Type 1 Diabetes
7. BioLineRx Announces Regulatory Submission for Phase 1/2 Trial for Novel Treatment of Celiac Disease
8. BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
9. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
10. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
11. BioLineRx to Present at 15th International Celiac Disease Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... first virtual care solution to empower health care systems with ... care service line, announced an agreement with Group Health ... use. Logo ... As health systems consider how to keep ... their own branded online care for common medical conditions. As ...
(Date:7/28/2015)... DUBLIN , July 21, 2015 ... the addition of the "Pharmaceutical Industry in ... Multinational and Chinese Biopharma Companies, Industry Trends, Environment, ... report to their offering. This ... in China but also ...
(Date:7/28/2015)... , July 28, 2015  Alere Inc. (NYSE: ... announced that it will release its financial results for ... will host a conference call beginning at 8:30 a.m. ... results and provide business updates. The ... Relations section of Alere,s website, or accessed directly through ...
Breaking Medicine Technology:Zipnosis Announces Group Health to use Virtual Care Service Line 2Zipnosis Announces Group Health to use Virtual Care Service Line 3Pharmaceutical Industry in China to 2020: Market to Increase Dramatically to $200 Billion 2Alere to Report Second Quarter 2015 Financial Results on August 4, 2015 2
... AMSTERDAM, The Netherlands, June 30 ... Major Impact on the Decision-Making Process With,Respect to Infertility ... an economic analysis presented today at this year,s,European Society ... the parameters of the simulation model used, the in ...
... ROCHESTER, Minn., June 29 Pioneering therapeutic trials to ... in hard-to-treat depression, obsessive-compulsive disorder (OCD) and Tourette,s ... according to a review in the June 2009 issue of ... . "Deep brain stimulation has long been seen as valuable ...
Cached Medicine Technology:New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 2New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 3New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 4Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 3
(Date:7/28/2015)... ... 2015 , ... Egg freezing is becoming an increasingly popular option ... As Dr. Michael Kettel explained in an article from the San ... for previous generations who had to make choices between their fertility and their career ...
(Date:7/28/2015)... San Antonio, TX (PRWEB) , ... July 28, 2015 , ... ... in Texas, is now offering the duodenal switch weight loss surgery procedure. ... weight management and bariatric surgery procedures, BMI of Texas is one of ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Bipolar disorder is ... a day to a few times a year. The World Health Organization (WHO) has ... the National Institute of Mental Health reveals that the United States has the highest ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... biologic-device combination products for the treatment of bone disorders and conditions of hair ... 9,062,300 entitled "Fusion Proteins of Collagen Binding-Domain and Parathyroid Hormone". The issued patent ...
(Date:7/28/2015)... York, NY (PRWEB) , ... July 28, 2015 ... ... benefit management services to include a proprietary, web based clinical knowledge system, called ... that are evidence based. It provides physicians who are anticipating making a ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 3Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 2Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 3Health News:"I Am Not I" Music Video Raises Bipolar Disorder Awareness 2Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:Introducing Care to Care’s New Web Based “Referral Guidance” Program 2
... Variations in Therapy Regimens, with Monotherapy Most Common in Elderly ... , ORLANDO, Fla., June 1 There are striking differences ... based on both age and geography, according to a new ... as a poster on Saturday at the 2009 ASCO (American ...
... ties to convicted lobbyist Jack Abramoff , , ... new investigative report today called "Viewers Beware of Anti-Health Care ... in eight states, including Montana, to oppose health care reform. ... Foundation, which has a record as a right-wing political operation ...
... , Group led by conservative political operative with ties to ... Public Campaign Action Fund issued a new investigative report ... the group behind the political ads running in eight states, ... funded by the Americans for Prosperity Foundation, which has a ...
... with ties to convicted lobbyist Jack Abramoff , , ... new investigative report today called "Viewers Beware of Anti-Health Care ... in eight states, including South Dakota, to oppose health care ... Foundation, which has a record as a right-wing political operation ...
... some also suffer PTSD years after treatment , MONDAY, ... aren,t following recommended guidelines on screenings for second cancers ... from post-traumatic stress disorder years after beating their disease, ... can be costly because childhood cancer survivors are more ...
... the Link between Healthy Living and Reducing Health Risks , ... -- Ten year olds aren,t typically at risk ... lead to stroke risk factors. A program run by Sacred ... a healthy lifestyle. In conjunction with parents and the ...
Cached Medicine News:Health News:New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography 2Health News:New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography 3Health News:'Viewers Beware' Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in Montana 2Health News:"Viewers Beware" Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in Indiana 2Health News:"Viewers Beware" Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in South Dakota 2Health News:Many Childhood Cancer Survivors Not Checking for Second Malignancies 2Health News:Many Childhood Cancer Survivors Not Checking for Second Malignancies 3Health News:Sacred Heart Hospital Starts to Expose Students to Stroke Awareness at an Early Age 2
... achieves optimum lung penetration for maximum therapeutic ... 1.04-1.10 µ at 6-8 LPM. Latex-free components. ... ,As the world leader in airway management ... of proven technology by offering top brands ...
... HOPE nebulizer the gold standard for continuous medication ... everything together in one convenient kit. You asked, ... Adult HOPE Kit which contains a HOPE nebulizer, ... mask all in one set up. This kit ...
... nebulizers offer a spill-proof design and effective ... 45° angle. All medical nebulizers are free-standing ... of configurations are available., ,All Portex® ... ,Portex® medication nebulizers feature consistently fine misting ...
... convenient, procedural kit contains everything the health ... challenge test quickly and efficiently: 7 nebulizers, ... tubing, syringe and needle., ,Shipped 5 ... the European Community., ,Intended Use: AsthmaKit ...
Medicine Products: